MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
NEW YORK--(BUSINESS WIRE) Mar 07, 2024 -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada MMED), (the“Company” or“MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 7, 2024 Category: Pharmaceuticals Source Type: clinical trials
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
DiscussionAlthough ME/CFS including PACS-CFS causes an immense individual, social, and economic burden, we lack efficient therapeutic options. The present study aims to investigate the efficacy of immunoadsorption and to contribute to the etiological understanding and establishment of diagnostic tools for ME/CFS.Trial registrationRegistration Number:NCT05710770. Registered on 02 February 2023. (Source: Trials)
Source: Trials - March 7, 2024 Category: Research Source Type: clinical trials
Type 1 Diabetes, Exercise and Mentoring Trial
Conditions: Type 1 Diabetes; Physical Activity Interventions: Behavioral: 12-week TEAM peer mentor program Sponsors: University of Manitoba; Juvenile Diabetes Research Foundation; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Open Lung Protective Extubation Following General Anesthesia
Conditions: Intra-abdominal Surgery; Anesthesia; Lung Injury; Ventilator-Induced Lung Injury; Atelectasis Interventions: Other: Protective " open-lung " extubation; Other: Conventional extubation Sponsors: Centre hospitalier de l ' Universit é de Montréal (CHUM); CHU de Quebec-Universite Laval; The Ottawa Hospital; University Health Network, Toronto; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
FOSTER CITY, Calif.,& RAHWAY, N.J.--(BUSINESS WIRE) March 06, 2024 -- Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 2 clinical study... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 6, 2024 Category: Pharmaceuticals Source Type: clinical trials
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery: A Pilot, Multi-centre, Placebo-controlled Randomized Trial
Conditions: Chronic Iron Deficiency Anaemia; Cardiac Surgery Interventions: Drug: Monoferric Injectable Product; Other: 0.9% sodium chloride solution Sponsors: University Health Network, Toronto; Queen ' s University; Sunnybrook Health Sciences Centre; Heart and Stroke Foundation of Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Canadian Bone Strength Development Study
Conditions: Type-1 Diabetes Sponsors: University of Saskatchewan; University of Calgary; The Hospital for Sick Children; Children ' s Hospital of Eastern Ontario Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
The Tryptophan Requirement in Healthy Adults
Conditions: Healthy Aging Interventions: Other: Tryptophan Sponsors: The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate
Conditions: Hemolysis; Renal Failure Interventions: Other: Bicarbonate Sponsors: McMaster University; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
A Novel Iron-Based Supplement for Athletes
Conditions: Iron Deficiencies Interventions: Other: FeSC Sponsors: University of Calgary; Mitacs; Natural Sciences and Engineering Research Council, Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
A Digital Active Aging Training Program for Older Adults
Conditions: Healthy Aging; Cognitive Change; Psychological Stress; Loneliness; Social Interaction Interventions: Behavioral: Resilience training; Behavioral: cognitive training; Behavioral: physical exercise; Behavioral: social interaction; Behavioral: workshop series Sponsors: Toronto Metropolitan University; Social Sciences and Humanities Research Council of Canada; AGE-WELL and the Canadian Frailty Network; Cogniciti; Cognifit; Aging in Cloud Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Detection of Endometrial Cancer Through Risk Modelling
Conditions: Endometrial Cancer Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Impact of Milk and Yogurt Supplementation on Bone Health, Body Composition, and Gut Microbiota in Canadian Young Adults
Conditions: Osteoporosis; Obesity Interventions: Other: Habitual Diet + Milk; Other: Habitual Diet + Yogurt Sponsors: University of Saskatchewan; Dairy Farmers of Canada; Agriculture and Agri-Food Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
M. Avium WGS During Mav-PD Treatment
Conditions: Mycobacterium Avium; Mycobacterium Infections, Nontuberculous; Mycobacterium Infections; Nontuberculous Mycobacterial Lung Disease; Respiratory Tract Diseases Interventions: Other: Whole genome sequencing testing Sponsors: University Health Network, Toronto; Western University, Canada; Public Health Ontario Laboratory, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome
Conditions: Fragile X Syndrome Interventions: Drug: CBD Oral Solution; Drug: Placebo Sponsors: Universit é de Sherbrooke; Canadian Institutes of Health Research (CIHR); Jazz Pharmaceuticals; Centre de recherche du Centre hospitalier universitaire de Sherbrooke Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
